FORTREA HOLDINGS INC. (FTRE) Operating Margin
- Operating margin · 12 months: Value -0.40%; Formula and calculation Operating income / revenue. Period ending 2026-06-30..
Operating margin
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Operating margin · 12 months | -0.40% | Operating income / revenue. Period ending 2026-06-30. $-10.80M ÷ $2.68B × 100 ≈ -0.40% |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Operating income | -10.80M USD | Operating Income (Loss) |
| Revenue | 2.68B USD | Revenue from Contract with Customer, Excluding Assessed Tax |
| Cost of products and services | (m) | |
| Research and development | (m) | |
| Selling, general and administration | 412.40M USD | Selling, General and Administrative Expense |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Operating income (USD) | Revenue (USD) | Cost of products and services (USD) | Research and development (USD) | Selling, general and administration (USD) | Operating margin |
|---|---|---|---|---|---|---|
| 2026-06-30 | $-10.80M | $2.68B | (m) | (m) | $412.40M | -0.40% |
| 2026-03-31 | $-355.90M | $2.71B | (m) | (m) | $435.10M | -13.14% |
| 2025-12-31 | $-872.60M | $2.72B | (m) | (m) | $456.40M | -32.04% |
| 2025-09-30 | $-914.60M | $2.76B | (m) | (m) | $501.50M | -33.14% |
| 2025-06-30 | $-924.00M | $2.73B | (m) | (m) | $531.00M | -33.80% |
| 2025-03-31 | $-644.60M | $2.69B | (m) | (m) | $562.40M | -24.00% |
| 2024-12-31 | $-161.90M | $2.70B | (m) | (m) | $560.70M | -6.00% |
| 2024-09-30 | $-130.30M | $2.71B | (m) | (m) | $539.30M | -4.81% |
| 2024-06-30 | $-102.00M | $2.75B | (m) | (m) | $509.80M | -3.71% |
| 2024-03-31 | $-19.50M | $2.81B | (m) | (m) | $451.40M | -0.69% |
| 2023-12-31 | $63.10M | $3.11B | (m) | (m) | $336.60M | 2.03% |
| 2023-09-30 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2023-06-30 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2023-03-31 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2022-12-31 | $235.90M | $3.10B | (m) | (m) | $279.80M | 7.62% |
| 2022-09-30 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2022-06-30 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2021-12-31 | $114.30M | $3.06B | (m) | (m) | $303.10M | 3.74% |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Personalis, Inc. (PSNL) | United States | $1.769B | -13.30 |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| CareDx, Inc. (CDNA) | United States | $3.174B | 13.21 |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| BIODESIX INC (BDSX) | United States | $0.312B | |
| EXAGEN INC. (XGN) | United States | $0.212B | -5.95 |
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| SERA PROGNOSTICS, INC. (SERA) | United States | $0.062B | -5.75 |
| AMERICAN SHARED HOSPITAL SERVICES (AMS) | United States | $0.010B | -5.64 |